Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.01 | uM | 7 | 156.25 | 33.46 | 110.00 | 100.50 | 1.0945 | 1.1171 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 110.00 | 100.50 | 1.0945 | 1.1171 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 111.00 | 100.50 | 1.1045 | 1.1293 | |
| SK-BR-3 | 17-AAG | 1 | uM | 7 | 156.25 | 33.46 | 90.00 | 100.50 | 0.8955 | 0.8656 |
| SK-BR-3 | Linsitinib | 10 | uM | 7 | 156.25 | 33.46 | 105.00 | 100.50 | 1.0448 | 1.0560 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 7 | 156.25 | 33.46 | 60.00 | 100.50 | 0.5970 | 0.4450 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 7 | 156.25 | 33.46 | 109.00 | 100.50 | 1.0846 | 1.1050 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 7 | 156.25 | 33.46 | 94.00 | 100.50 | 0.9353 | 0.9175 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 7 | 156.25 | 33.46 | 110.00 | 100.50 | 1.0945 | 1.1171 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 120.00 | 100.50 | 1.1940 | 1.2365 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 7 | 156.25 | 33.46 | 108.00 | 100.50 | 1.0746 | 1.0928 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 102.00 | 100.50 | 1.0149 | 1.0188 | |
| SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 156.25 | 33.46 | 97.00 | 100.50 | 0.9652 | 0.9558 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 7 | 156.25 | 33.46 | 117.00 | 100.50 | 1.1642 | 1.2011 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 7 | 156.25 | 33.46 | 83.00 | 100.50 | 0.8259 | 0.7728 |
| SK-BR-3 | Erlotinib | 1 | uM | 7 | 156.25 | 33.46 | 89.00 | 100.50 | 0.8856 | 0.8526 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 7 | 156.25 | 33.46 | 95.00 | 100.50 | 0.9453 | 0.9303 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 33.46 | 74.00 | 100.50 | 0.7363 | 0.6491 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 79.00 | 100.50 | 0.7861 | 0.7185 | |
| SK-BR-3 | 17-AAG | 3.1623 | uM | 7 | 156.25 | 33.46 | 60.00 | 100.50 | 0.5970 | 0.4450 |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 147.00 | 100.50 | 1.4627 | 1.5416 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 100.50 | 0.0199 | -0.8306 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 2.00 | 100.50 | 0.0199 | -0.8306 | |
| SK-BR-3 | 0 | uM | 7 | 156.25 | 33.46 | 80.00 | 100.50 | 0.7960 | 0.7322 | |
| SK-BR-3 | 17-AAG | 10 | uM | 7 | 156.25 | 33.46 | 106.00 | 100.50 | 1.0547 | 1.0683 |